@article{APS3801,
author = {Chun-jian Li and Jun Huang and Zhi-jian Yang and Ke-jiang Cao},
title = {Thrombolytic efficacy of native recombinant staphylokinase on femoral artery thrombus of rabbits},
journal = {Acta Pharmacologica Sinica},
volume = {28},
number = {1},
year = {2016},
keywords = {},
abstract = {Aim: To investigate the thrombolytic efficacy, ideal dosage and administration of
native recombinant staphylokinase (r-SAK). Methods: Forty New Zealand rabbits
were randomly assigned into the control, r-SAK low-dose, medial-dose, highdose,
single bolus, allied therapy, recombinant streptokinase (r-SK) and urokinase
(UK) groups. The right femoral artery thrombosis models were made by
balloon injury, and 120 min after the injury, the thrombolytic agents were infused
through the rabbits’ parallel-ear vein. Results: (1) 2 h after balloon injury, the
pulse pressures of the right femoral arteries reduced to 0 or less than 10% of that
of left femoral arteries in all groups; (2) after thrombolytic therapy, the pulse
pressures in some of the femoral arteries markedly enhanced to more than 50% of
that of left femoral arteries; (3) the reopening rates in the r-SAK medial and highdose
groups were significantly higher than that of the control. The reopening rate
of the same dose native r-SAK was significant higher than that of UK and r-SK; (4)
the patency score of the right femoral arteries tended to be better in the r-SAK
medial and high-dose groups than that of the low-dose group, and the time to
reopening in the allied therapy group tended to be shorter. Conclusion: (1) r-SAK
has a definite thrombolytic effect on the femoral artery thrombus of rabbits; (2)
single bolus is an effective manner of r-SAK therapy, and r-SAK allied therapy
with heparin may shorten the time to recanalization; (3) the efficacy of the same
dose native r-SAK was superior to that of r-SK and UK.},
issn = {1745-7254}, url = {http://www.chinaphar.com/article/view/3801}
}